TechsoMed Raises $7 Million Series B financing led by Axil Capital

05 Mar, 2021

TechsoMed Raises $7 Million Series B financing led by Axil Capital
Photo by Asaf Gazit on Unsplash

– TechsoMed has raised $7m in Series B financing led by Axil Capital.
– The company is developing a first of its kind AI and Algorithm powered real-time tissue damage imaging technology.
– TechsoMed is collaborating with leading medical centers world-wide, in efforts to secure regulatory approval for its BioTrace system in liver tumor ablation through the De Novo process established by the FDA. In parallel, the BioTrace system is also being developed to support cardiac and pain ablation procedures.

Asia Biotechnology Health Care
Crunchbase icon

Content report

The following text will be sent to our editors: